Derivation and application of relative potency estimates based on in vitro bioassay results

Relative potency (REP) estimates are widely used to characterize and compare the potency of a wide variety of samples analyzed using in vitro bioassays. Relative potency estimates are generally calculated as a simple ratio: the EC50 of a well-characterized standard divided by the EC50 of a sample. Such estimates are valid only when the dose-response curves for the sample and standard are parallel and exhibit the same maximum achievable response (efficacy). These conditions are often either violated or cannot be demonstrated. As a result, there is a need to calculate and present REPs in a manner that addresses the potential uncertainties caused by violation of the assumptions of parallelism and equal efficacy. Multiple point estimates, over the range of responses from EC20 to EC80, can be used to derive relative potency ranges (REP 20 80 range). The width of a REP 20-80 range is directly proportional to the degree of deviation from parallelism between sample and standard dose-response curves. Thus, REP 20 80 ranges both test the assumption of parallelism and characterize the amount of uncertainty in an REP estimate resulting from deviation from parallelism. Although uncertainties due to unequal efficacy cannot be easily characterized mathematically, a systematic method for evaluating sample efficacy has been developed into a framework to guide the derivation and application of REP estimates based on in vitro bioassay results. Use of the systematic framework and REP 20 80 o ranges was illustrated using three sample data sets. It is hoped that the framework and discussion presented will facilitate the use of bioassay-derived REP estimates to characterize samples of both known and unknown composition without ignoring the assumptions underlying REP estimation.

[1]  J. Meador,et al.  Modeling dose response using generalized linear models , 1996 .

[2]  J. Giesy,et al.  H4IIE rat hepatoma cell bioassay-derived 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents in colonial fish-eating waterbird eggs from the Great Lakes , 1991, Archives of environmental contamination and toxicology.

[3]  J. Giesy,et al.  Characterization and distribution of trace organic contaminants in sediment from Masan Bay, Korea. 2: In vitro gene expression assays , 1999 .

[4]  John P. Giesy,et al.  Congener profile of polychlorinated/brominated dibenzo‐p‐dioxins and dibenzofurans in soil and sediments collected at a former chlor‐alkali plant , 1998 .

[5]  J. L. Zajicek,et al.  Dietary Exposure of Mink to Carp from Saginaw Bay. , 1996 .

[6]  R M Putzrath,et al.  Estimating relative potency for receptor-mediated toxicity: reevaluating the toxicity equivalence factor (TEF) model. , 1997, Regulatory toxicology and pharmacology : RTP.

[7]  Dwayne R.J. Moore,et al.  A spreadsheet program for estimating low toxic effects , 1997 .

[8]  J. Giesy,et al.  Characterization and Distribution of Trace Organic Contaminants in Sediment from Masan Bay, Korea. 1. Instrumental Analysis , 1999 .

[9]  J. Giesy,et al.  Polychlorinated dibenzo‐p‐dioxins, dibenzofurans, biphenyls and 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin equivalents in fishes from Saginaw Bay, Michigan , 1997 .

[10]  C. Richter,et al.  Rainbow trout cell bioassay‐derived relative potencies for halogenated aromatic hydrocarbons: Comparison and sensitivity analysis , 1999 .

[11]  J. Giesy,et al.  Vertical profile of dioxin-like and estrogenic potencies in a sediment core from Tokyo Bay, Japan. , 2000, Central European journal of public health.

[12]  John P. Giesy,et al.  An in vitro rainbow trout cell bioassay for aryl hydrocarbon receptor‐mediated toxins , 1997 .

[13]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[14]  S. Safe,et al.  Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). , 1990, Critical reviews in toxicology.

[15]  John P. Giesy,et al.  Isomer-Specific Analysis and Toxic Evaluation of Polychlorinated Naphthalenes in Soil, Sediment, and Biota Collected near the Site of a Former Chlor-Alkali Plant , 1998 .

[16]  D. Versteeg,et al.  A statistical procedure for modeling continuous toxicity data , 1992 .

[17]  J. Giesy,et al.  Comparison of Ah receptor-mediated luciferase and ethoxyresorufin-O-deethylase induction in H4IIE cells: implications for their use as bioanalytical tools for the detection of polyhalogenated aromatic hydrocarbons. , 1996, Toxicology and applied pharmacology.

[18]  A. John Bailer,et al.  Estimating inhibition concentrations for different response scales using generalized linear models , 1997 .

[19]  A. John Bailer,et al.  Equivalence of concentration–response relationships in aquatic toxicology studies: Testing and implications for potency estimation , 1997 .

[20]  N A Cressie,et al.  Analysing data from hormone-receptor assays. , 1981, Biometrics.

[21]  E. R. Christensen,et al.  Statistical treatment of data from microbial toxicity tests , 1992 .

[22]  D. Moore,et al.  Estimating low toxic effects , 1997 .

[23]  S. Tanabe,et al.  Distribution and Characterization of Polychlorinated Biphenyl Congeners in Soil and Sediments from a Superfund Site Contaminated with Aroclor 1268 , 1997 .

[24]  Gary M. Rand,et al.  Fundamentals of aquatic toxicology: effects, environmental fate, and risk assessment , 1995 .

[25]  T. Zacharewski,et al.  Detection of Estrogen- and Dioxin-like Activity in Pulp and Paper Mill Black Liquor and Effluent Using in vitro Recombinant Receptor/Reporter Gene Assays. , 1995, Environmental science & technology.

[26]  J. Giesy,et al.  Alkylphenols, polycyclic aromatic hydrocarbons, and organochlorines in sediment from Lake Shihwa, Korea: Instrumental and bioanalytical characterization , 1999 .

[27]  M. Romkes,et al.  Development and validation of in vitro bioassays for 2,3,7,8-TCDD equivalents , 1989 .